Complication probability as assessed from dose-volume histograms.
about
Focus on treatment complications and optimal management: radiation oncologyIncorporating GSA-SPECT into CT-based dose-volume histograms for advanced hepatocellular carcinoma radiotherapyCoverage-based treatment planning to accommodate deformable organ variations in prostate cancer treatmentA dose-volume histogram based decision-support system for dosimetric comparison of radiotherapy treatment plans.Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort.Critical volume model analysis of lung complication data from different strains of mice.Using patient data similarities to predict radiation pneumonitis via a self-organizing mapFocal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.Response-driven imaging biomarkers for predicting radiation necrosis of the brainParotid gland function after radiotherapy: the combined michigan and utrecht experience.A computational tool for the efficient analysis of dose-volume histograms from radiation therapy treatment plans.The different dose-volume effects of normal tissue complication probability using LASSO for acute small-bowel toxicity during radiotherapy in gynecological patients with or without prior abdominal surgery.Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelCurative effect of stereotactic body radiotherapy on hepatic hilar carcinoma.Pleural intensity-modulated radiotherapy for malignant pleural mesotheliomaDosimetric effect of tissue heterogeneity for (125)I prostate implantsComparison of prostate IMRT and VMAT biologically optimised treatment plans.On Voxel based Iso-Tumor Control Probabilty and Iso-Complication Maps for Selective Boosting and Selective Avoidance Intensity Modulated Radiotherapy.Development and evaluation of convergent and accelerated penalized SPECT image reconstruction methods for improved dose-volume histogram estimation in radiopharmaceutical therapy.A neural network model to predict lung radiation-induced pneumonitis.Dose mapping sensitivity to deformable registration uncertainties in fractionated radiotherapy - applied to prostate proton treatmentsMethodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop.Reduced order constrained optimization (ROCO): clinical application to lung IMRT.Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomiaCyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerations.Estimation of α/β for late rectal toxicity based on RTOG 94-06Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides.Prospective longitudinal assessment of parotid gland function using dynamic quantitative pertechnate scintigraphy and estimation of dose-response relationship of parotid-sparing radiotherapy in head-neck cancers.Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.Visualization of risk of radiogenic second cancer in the organs and tissues of the human body.Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).On voxel-by-voxel accumulated dose for prostate radiation therapy using deformable image registration.Mean Organ Doses Resulting From Non-Human Primate Whole Thorax Lung Irradiation Prescribed to Mid-Line TissueRadiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study.Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06.Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.Analysis of radiation pneumonitis risk using a generalized Lyman model.
P2860
Q26824398-6767B295-307A-4733-8D0B-D7F13A0133DCQ27030865-F0BE9E4A-F382-4A02-B583-BB1CF951604CQ30303159-F4A90BB9-6DC5-4117-895A-B56A071B7F31Q30395188-95373CE9-22B2-4AC5-8FD5-CBC5C180FEA1Q30402671-B90B70C7-550C-4BBF-AF86-FAEE2F72267CQ30664267-70C9A074-7AB8-40F1-81B9-3B3C39F48818Q30992316-B0DD854A-5988-453C-AB1B-AE670C09A7B8Q31142281-DB05F38B-6F16-477C-A24A-B2BEDC7E4860Q33550577-E69B9077-37F2-43C9-A5C4-50555AF7F49EQ33856198-A775CA1A-A92B-408F-9D56-481CEEEC0C07Q33927574-2C520306-4EF7-4675-824E-875288E800E5Q33961621-D9E91666-E2DE-4722-A17E-B51C441BD1BAQ34014421-1DD6D413-4819-475E-AE86-12F6FEC36590Q34161145-6074B966-D73D-4004-9002-E77ACFB6C006Q34211377-E05AE897-E43C-4C38-8721-03AE8D05119EQ34238364-FDA05609-D372-4BBA-B52F-3061B18F847DQ34265934-D554AF79-BF82-45C9-8384-9173BC49FC41Q34274850-D9A036E1-0FB9-4387-BB64-9840873BF668Q34363645-86B2CDE4-BD6C-427B-85A2-46AAFE0DA22AQ34372750-DBACB1AC-E76F-4304-9257-F9F75ECFCFF7Q34399725-BAD715C2-23FD-43E3-B515-DCF34CA53B7FQ34563194-CA5589BE-8866-4355-97E4-09B02712755CQ34699983-7179AF4B-3BDE-4F9C-8CC6-7167A89A0749Q34773793-97F4CD91-55F8-4204-96B5-7B9A7C0C6AE9Q34913450-2738C493-7DCE-4851-A9E6-983A64850D3AQ35023746-CD0666C8-ADCD-42F1-B089-C3DC68779861Q35030231-928F22C6-9420-4C3C-BFDA-BF10591D2052Q35059298-F92FC5F0-D20F-4086-922F-9CA520F18418Q35186584-0732DF17-C044-4C65-988C-274F3658C434Q35202977-6564D9A8-9865-4B58-8B93-38844C9B382FQ35215496-3BF1A74E-4A32-4663-9D78-FD799D4A598CQ35515150-BAC49475-C598-42A4-82D5-20CEC33EAF06Q35576919-FE9A230D-C044-479C-AC5A-82138002D36DQ35669846-D043E109-E7D7-45B3-B63F-C3ED74DCB463Q36011188-95FF99F8-2CB9-4A3C-98F7-859D7436FF0CQ36120972-0ED9495E-4D50-4A3E-B1AB-0ABB9D094475Q36124529-1CA1E771-9873-476A-BE26-C11077B385CDQ36145910-ACEA004D-8C9F-4E79-A07E-BD2E0B365660Q36202855-0AB3C7AB-C4F1-4D85-9FD6-EC74BAADF341Q36235629-F9072B6D-6CEC-44CC-B3E6-FD467C6A0963
P2860
Complication probability as assessed from dose-volume histograms.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Complication probability as assessed from dose-volume histograms.
@en
Complication probability as assessed from dose-volume histograms.
@nl
type
label
Complication probability as assessed from dose-volume histograms.
@en
Complication probability as assessed from dose-volume histograms.
@nl
prefLabel
Complication probability as assessed from dose-volume histograms.
@en
Complication probability as assessed from dose-volume histograms.
@nl
P356
P1476
Complication probability as assessed from dose-volume histograms.
@en
P2093
P356
10.2307/3583506
P577
1985-01-01T00:00:00Z